Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Tomography, Emission-Computed »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tomography Scanners, X-Ray Computed < Tomography, Emission-Computed < Tomography, Emission-Computed (methods)  Facettes :

List of bibliographic references indexed by Tomography, Emission-Computed

Number of relevant bibliographic references: 86.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000689 (2014) Andre C. Felicio [Canada] ; Katherine Dinelle [Canada] ; Pankaj A. Agarwal [Canada] ; Jessamyn Mckenzie [Canada] ; Nicole Heffernan [Canada] ; Jeremy D. Road [Canada] ; Silke Appel-Cresswell [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [Canada] ; Michael Schulzer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada]In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers
001829 (2011) Catherine L. Gallagher [États-Unis] ; Bradley T. Christian [États-Unis] ; James E. Holden [États-Unis] ; Onofre T. Dejesus [États-Unis] ; Robert J. Nickles [États-Unis] ; Laura Buyan-Dent [États-Unis] ; Barbara B. Bendlin [États-Unis] ; Sandra J. Harding [États-Unis] ; Charles K. Stone [États-Unis] ; Barb Mueller [États-Unis] ; Sterling C. Johnson [États-Unis]A within‐subject comparison of 6‐[18F]fluoro‐m‐tyrosine and 6‐[18F]fluoro‐L‐dopa in Parkinson's disease
003A81 (2004) Karsten Henkel [Allemagne] ; Jochen Karitzky [Allemagne] ; Michaela Schmid [Allemagne] ; Irina Mader [Allemagne] ; Gerhard Glatting [Allemagne] ; Jürgen W. Unger [Allemagne] ; Bernd Neumaier [Allemagne] ; Albert C. Ludolph [Allemagne] ; Sven N. Reske [Allemagne] ; G. Bernhard Landwehrmeyer [Allemagne]Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration
003A89 (2004) Atsuko Nagano-Saito [Japon] ; Yukihiko Washimi [Japon] ; Yutaka Arahata [Japon] ; Katsushige Iwai [Japon] ; Shoji Kawatsu [Japon] ; Kengo Ito [Japon] ; Akinori Nakamura [Japon] ; Yuji Abe [Japon] ; Takako Yamada [Japon] ; Takashi Kato [Japon] ; Teruhiko Kachi [Japon]Visual hallucination in Parkinson's disease with FDG PET
003B82 (2004) Sarah Furtado [Canada] ; Haydeh Payami [États-Unis] ; Paul J. Lockhart [États-Unis] ; Melissa Hanson [États-Unis] ; John G. Nutt [États-Unis] ; Andrew A. Singleton [États-Unis] ; Amanda Singleton [États-Unis] ; Jamel Bower [États-Unis] ; Ryan J. Utti [États-Unis] ; Thomas D. Bird [États-Unis] ; Raul De La Fuente-Fernandez [Canada] ; Yoshio Tsuboi [États-Unis] ; Mary L. Klimek [Canada] ; Oksana Suchowersky [Canada] ; John Hardy [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; A. Jon Stoessl [Canada]Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2)
003D79 (2004) Shinji Saiki [Japon] ; Genjiro Hirose [Japon] ; Koichiro Sakai [Japon] ; Ichiro Matsunari [Japon] ; Kotaro Higashi [Japon] ; Misuzu Saiki [Japon] ; Satoshi Kataoka [Japon] ; Ariyuki Hori [Japon] ; Kohei Shimazaki [Japon]Chorea‐acanthocytosis associated with tourettism
003D80 (2004) L. Vela [États-Unis] ; G. N. Sfakianakis [États-Unis] ; D. Heros [États-Unis] ; W. Koller [États-Unis] ; C. Singer [États-Unis]Chorea and contraceptives: Case report with pet study and review of the literature
003D85 (2004) Elan D. Louis [États-Unis] ; Dikoma C. Shungu [États-Unis] ; Xiangling Mao [États-Unis] ; Steven Chan [États-Unis] ; Eva C. Jurewicz [États-Unis]Cerebellar metabolic symmetry in essential tremor studied with 1H magnetic resonance spectroscopic imaging: Implications for disease pathology
003D87 (2004) Nicola Pavese [Royaume-Uni] ; Ornella Rimoldi [Royaume-Uni] ; Alexander Gerhard [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola Piccini [Royaume-Uni]Cardiovascular effects of methamphetamine in Parkinson's disease patients
003E15 (2004) Akio Kikuchi [Japon] ; Atsushi Takeda [Japon] ; Kazuo Fujihara [Japon] ; Teiko Kimpara [Japon] ; Yusei Shiga [Japon] ; Hiroaki Tanji [Japon] ; Makiko Nagai [Japon] ; Hiroshi Ichinose [Japon] ; Fumi Urano [Japon] ; Nobuyuki Okamura [Japon] ; Hiroyuki Arai [Japon] ; Yasuto Itoyama [Japon]Arg(184)his mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa‐responsive dystonia with parkinsonism: A case report
003E31 (2004) Carl E. Clarke [Royaume-Uni]A “cure” for Parkinson's disease: Can neuroprotection be proven with current trial designs?
003E89 (2003) Stephen J. Kish [Canada]What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
003E96 (2003) David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni]Use of functional imaging in parkinsonism and dementia
003F10 (2003) Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
003F37 (2003) Klaus L. Leenders [Pays-Bas]Significance of non‐presynaptic SPECT tracer methods in Parkinson's disease
003F46 (2003) Kirn R. Kessler [Allemagne] ; Gilbert Wunderlich [Allemagne] ; Harald Hefter [Allemagne] ; Rüdiger J. Seitz [Allemagne]Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density
003F52 (2003) Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]Role of dopamine transporter imaging in routine clinical practice
003F53 (2003) Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
003F54 (2003) Wolfgang H. Oertel [Allemagne] ; Anja Gerstner [Allemagne] ; Helmut Höffken [Allemagne] ; Richard C. Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Jens C. Möller [Allemagne]Role of dopamine transporter SPECT for the practitioner and the general neurologist
003F75 (2003) P. K. Morrish [Royaume-Uni]REAL and CALM: What have we learned?
004070 (2003) Paul K. Morrish [Royaume-Uni]How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Tomography, Emission-Computed" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Tomography, Emission-Computed" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Tomography, Emission-Computed
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024